Michael Conjalka is an Oncology physician affiliated with St. Luke's-Roosevelt Hospital Center. OpenAlex indexes 8 publications with 340 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Roe Avenue
Falck Cancer Center
Elmira, NY 149051629
Telephone
607-737-8165Registry record last updated 16 Feb 2018.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20241 payment
- Myriad Genetic Laboratories, Inc.Program year20231 payment
- E.R. Squibb & Sons, L.L.C.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
28.7%Antimetabolite8.1%Hydroxyurea100%Part D≥16 patientsAromatase Inhibitor7.9%Anastrozole68%Letrozole32%Part D<11 patients+ 4 more classes in this area
Blood & clotting
27.5%Factor Xa inhibitor21.3%Eliquis73%Xarelto27%Part D<11 patientsVitamin K antagonist3.7%Warfarin Sodium100%Part D≥11 patients+ 1 more class in this area
Nervous system
17.1%Opioid Agonist7.9%Oxycodone Hcl60%Fentanyl23%Morphine Sulfate17%Part D<11 patientsGabapentinoids1.9%Gabapentin100%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Saurav Chatterjee, MD, FACC, FSCAI
St. Luke's-Roosevelt Hospital Center
Maureen Cafferty, MD
St. Luke's-Roosevelt Hospital Center
Steven Wager, MD
St. Luke's-Roosevelt Hospital Center
Ellen Teplitz, MD
St. Luke's-Roosevelt Hospital Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”